Peter Mueller

Filings by Peter Mueller span 2 companies, the busiest being Vertex Pharmaceuticals INC / MA and BioXcel Therapeutics, Inc. Over a trading history stretching from 6 January 2006 to 23 August 2019, the count stands at 205 filings.

On the open market, the record shows 12 purchases worth €137k and 117 sales worth €25.1M. On balance, insiders were net sellers of €24.9M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 10 share grants and 63 option exercises.

Half of the purchases are above €5,264 and half below. Clusters matter here: 3 out of 3 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

Most recently, on 14 February 2020, the filings show a transaction in BioXcel Therapeutics, Inc. The latest purchase dates back some time: it was published 2,631 days ago, on 26 August 2019. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.